Skip to main content

Table 5 Primary outcomes for patients with PSC

From: Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]

  Placebo (n = 6) Fluvoxamine (n = 5)
  Day 0 Day 14 Day 42 Day 70 Day 0 Day 14 Day 42 Day 70
VAS Fatigue 7.3 7.4 7.5 8.3 6.4 6.8 7.5 7.9
FFSS
   Physical Domain 14 13 9 9 28 27 26 28
   Cognitive Domain 8 11 8 7 20 20 19 18
   Social Domain 17 12 11 13 48 49 47 48
MFI
   General Fatigue 18 18 17 17 19 19 19 20
   Physical Fatigue 13 15 14 13 18 19 19 19
   Reduction Activity 12 12 11 12 18 18 17 20
   Reduction Motivation 10 10 8 8 18 17 18 16
   Mental Fatigue 12 10 10 11 14 14 13 13
  1. Results are expressed as median scores.